None
Conditions
Interventions
Control group:3µg/kg dexmedetomidine nasal spray
Experimental group 1:0.82mg/kg midazolam solution orally + sevoflurane for single inhalation inhalation
Experimental group 2:3µg/kg dexmedetomidine nasal spray+ sevoflurane for single inhalation inhalation
Sponsors
Xi'an International Medical Center Hospital
Eligibility
Sex/Gender
All
Age
1 Years to 6 Years
Inclusion criteria
Inclusion criteria: 1. children undergoing outpatient magnetic resonance examination (single site); 2. Age 1-6 years old, gender unlimited; 3. ASA Grade I-II; 4. The legal guardian of the child is willing to participate in this study and sign the informed consent.
Exclusion criteria
Exclusion criteria: 1. Allergy to the study drug; 2. Suffering from systemic disease with severe organ dysfunction; 3. Those who have a history of intellectual disability or cognitive impairment and are unable to cooperate; 4. Guardian's refusal to participate in the study; 5. Other reasons that, in the opinion of the investigator, preclude continuation of treatment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The success rate of MRI sedation in children; | — |
Secondary
| Measure | Time frame |
|---|---|
| Children's behavior scores at the time of drug administration;Children's modified sedation Ramsay score every 5 minutes after taking the drug;Time from initiation of dosing to entry into the examination room;Maximum depth of sedation score;The child maintained the behavior score when the child was separated from the parents;Radiologist satisfaction and parent satisfaction;Radiologist satisfaction and parent satisfaction; | — |
Countries
China
Contacts
Public ContactHongfei Xiong
Xi'an International Medical Center Hospital
Outcome results
None listed